Downregulation of IL-7 may explain the cytokine-independent activation of STAT3 and STAT5 in CTCL at advanced stages driven exclusively by constitutively active JAK1 and JAK3 kinases. The gene discussed is JAK3; the disease is primary cutaneous T-cell non-Hodgkin lymphoma.